Welcome
Programme
Contributors
Registration
Sponsorship

General Information

Building on the great achievement of the second edition of the EURETINA Innovation Spotlight (EIS), we are keeping the momentum going and hosting EIS 2025 on Wednesday, 3 September, at the Palais des Congrès Paris, preceding the EURETINA Annual Congress.

What is it?
 

The 6-hour Spotlight will include panel discussions and talks by selected Industry Leaders, Biomedical Innovators, Regulators and Investors, as well as networking opportunities.

We will be covering the many exciting areas of biomedical and engineering innovation in retina.

When is it?

EIS will take place on Wednesday 3 September 2025 at the Palais des Congrès Paris. The full schedule and programme information will be updated in due course.

Who is it for?

The goal of EIS is to foster collaboration, communication and contact directly between industry, regulators, investors, researchers and physicians involved or interested in the retinal innovation space. 

For Further Information

Please contact [email protected] for registration information and [email protected] for sponsorship options.

Letter from the President & EIS Committee

Dear Colleagues,

We are thrilled to announce the third edition of the Euretina Innovation Spotlight (EIS) to take place at the 25th Euretina Congress in Paris on Wednesday, 3rd September 2025.

EIS offers an engaging programme of panel discussions and talks, which has been curated directly by members of the Euretina Executive and Board. The meeting attracts key opinion leaders in the field of ophthalmology, including physicians, researchers, regulators, and investors. It offers a dynamic platform for collaboration and networking in retinal innovation, and we are very excited to build on the momentum of our past two successful events.

EIS ’25 also sees the introduction of a quick-fire session dedicated to emerging biotech companies to present their strategies in cutting-edge innovations in retina. Submissions will be accepted during a limited period and presentation slots are extremely limited.

Lastly, we are excited to once again offer a variety of sponsorship opportunities, and we warmly invite our industry partners to join our those already enlisted to support EIS ‘25. We look forward to collaborating in developing EIS into one of the most significant and influential meetings in the field of retinal innovation.

Warm regards,

Anat Loewenstein
President, Euretina

On behalf of the EIS Committee